These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cholera toxin. van Heyningen S Biosci Rep; 1982 Mar; 2(3):135-46. PubMed ID: 6121589 [No Abstract] [Full Text] [Related]
3. Host response to Escherichia coli heat-labile enterotoxin via two microvillus membrane receptors in the rat intestine. Zemelman BV; Chu SH; Walker WA Infect Immun; 1989 Oct; 57(10):2947-52. PubMed ID: 2674013 [TBL] [Abstract][Full Text] [Related]
4. [Recent knowledge on bacterial protein toxins]. Takeda Y Tanpakushitsu Kakusan Koso; 1986 Mar; 31(4 Suppl):281-7. PubMed ID: 3520678 [No Abstract] [Full Text] [Related]
5. Mechanism of action of choleragen and E. coli heat-labile enterotoxin: activation of adenylate cyclase by ADP-ribosylation. Moss J; Vaughan M Mol Cell Biochem; 1981 Jul; 37(2):75-90. PubMed ID: 6268961 [No Abstract] [Full Text] [Related]
7. Regulation by butyrate of the cAMP response to cholera toxin and forskolin in pituitary GH1 cells. Aranda A; Toro MJ; Usera F; Pascual A Eur J Biochem; 1990 Feb; 187(3):683-9. PubMed ID: 2154380 [TBL] [Abstract][Full Text] [Related]
8. The chemistry and biology of cholera toxin. Lai CY CRC Crit Rev Biochem; 1980; 9(3):171-206. PubMed ID: 6256124 [No Abstract] [Full Text] [Related]
9. Role of membrane gangliosides in the binding and action of bacterial toxins. Fishman PH J Membr Biol; 1982; 69(2):85-97. PubMed ID: 6752418 [TBL] [Abstract][Full Text] [Related]
10. Cholera toxin and related enterotoxins as potent immune modulators. Hirst TR; Nashar TO; Pitman RS; Williams NA Symp Ser Soc Appl Microbiol; 1998; 27():26S-34S. PubMed ID: 9750359 [No Abstract] [Full Text] [Related]
12. Actions of cholera toxin and the prevention and treatment of cholera. Holmgren J Nature; 1981 Jul; 292(5822):413-17. PubMed ID: 7019725 [TBL] [Abstract][Full Text] [Related]
13. [Use of the toxin-tissue receptor reaction for detecting toxic substances of the causative agents of acute intestinal diseases]. Bunin KB; Efremenko VI; Dolmatova LA; Cherchenko II; Nechaeva IP Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):63-5. PubMed ID: 6342315 [TBL] [Abstract][Full Text] [Related]
14. Toxin ADP-ribosyltransferases that act on adenylate cyclase systems. Moss J; Vaughan M Methods Enzymol; 1984; 106():411-8. PubMed ID: 6092833 [No Abstract] [Full Text] [Related]
15. [The cAMP system and bacterial toxins]. Kather H; Aktories K Klin Wochenschr; 1983 Nov; 61(22):1109-14. PubMed ID: 6317939 [TBL] [Abstract][Full Text] [Related]
16. Toxin receptors and their pathogenetic significance. Gyr K Acta Histochem Suppl; 1984; 29():95-102. PubMed ID: 6425929 [TBL] [Abstract][Full Text] [Related]
17. [Cholera research 100 years after its discovery--current topics]. Zinnaka Y Nihon Saikingaku Zasshi; 1984 Jul; 39(4):713-31. PubMed ID: 6094878 [No Abstract] [Full Text] [Related]
20. Mechanism of action of cholera toxin: effect of receptor density and multivalent binding on activation of adenylate cyclase. Fishman PH; Atikkan EE J Membr Biol; 1980; 54(1):51-60. PubMed ID: 6259358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]